A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and facial droop on the left side.

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...